PUBLIC ACCESS INFORMATION PORTAL

CIRCULAR 24 OF 2025 FEE SCHEDULE
CIRCULAR 24 OF 2025 FEE SCHEDULE
CIRCULAR 23 OF 2025 PUBLICATION OF CANCELLED WHOLESALE DEALER’S PERMITS PHARMACY LICENCES AND PERSONS’ LICENCES
CIRCULAR 23 OF 2025 PUBLICATION OF CANCELLED WHOLESALE DEALER’S PERMITS PHARMACY LICENCES AND PERSONS’ LICENCES
Size: 317 KB
Published: September 5, 2025
CIRCULAR 22 OF 2025 GUIDELINES FOR IMPLEMENTING TRACEBILITY FOR MEDICAL PRODUCTS IN ZIMBABWE
CIRCULAR 22 OF 2025 GUIDELINES FOR IMPLEMENTING TRACEBILITY FOR MEDICAL PRODUCTS IN ZIMBABWE
Size: 105KB
Published: July 29, 2025
CIRCULAR 21 OF 2025 ALERT ON FALSIFIED CLOXACILLIN 250MG CAPSULES DISTRIBUTED BY UNAUTHORISED SOURCES
CIRCULAR 21 OF 2025 ALERT ON FALSIFIED CLOXACILLIN 250MG CAPSULES DISTRIBUTED BY UNAUTHORISED SOURCES
Size: 248KB
Published: July 25, 2025
Circular 20 of 2025/Call for Submission of Applications for Registration Through the Expedited Review Pathway for Veterinary Medicinal Products – Phase II
Circular 20 of 2025/Call for Submission of Applications for Registration Through the Expedited Review Pathway for Veterinary Medicinal Products – Phase II
Size: 188 KB
Published: July 15, 2025
Circular 19 of 2025/Call for submission of applications for approval of complementary medicines through the expedited review pathways – Phase 1 of 2025
Circular 19 of 2025/Call for submission of applications for approval of complementary medicines through the expedited review pathways – Phase 1 of 2025
Size: 146 KB
Published: July 15, 2025
Circular 18 of 2025/Rev 00/Launch of an electronic new issuance module
Circular 18 of 2025/Rev 00/Launch of an electronic new issuance module
Size: 845 KB
Published: July 15, 2025
CIRCULAR 17 OF 2025 _ CALL FOR SUBMISSION OF APPLICATIONS FOR REGISTRATION OF HUMAN ALLOPATHIC MEDICINES THROUGH THE EXPEDITED REVIEW PATHWAY_ PHASE 11 OF 2025
CIRCULAR 17 OF 2025 _ CALL FOR SUBMISSION OF APPLICATIONS FOR REGISTRATION OF HUMAN ALLOPATHIC MEDICINES THROUGH THE EXPEDITED REVIEW PATHWAY_ PHASE 11 OF 2025
Size: 264 KB
Published: June 30, 2025
Circular 16 of 2025: PUBLICATION OF SUMMARISED PUBLIC ASSESSMENT REPORTS FOR CLINICAL TRIAL APPLICATIONS AND PUBLIC INSPECTION REPORTS FOR GOOD CLINICAL TRIAL PRACTICE (GCP) INSPECTIONS
Circular 16 of 2025: PUBLICATION OF SUMMARISED PUBLIC ASSESSMENT REPORTS FOR CLINICAL TRIAL APPLICATIONS AND PUBLIC INSPECTION REPORTS FOR GOOD CLINICAL TRIAL PRACTICE (GCP) INSPECTIONS
Size: 694 KB
Published: June 22, 2025
Circular 15 of 2025-Notification for Publication of Public Inspection Reports
Circular 15 of 2025-Notification for Publication of Public Inspection Reports
Size: 5002 KB
Published: June 22, 2025
1 2 3 4
Circular-17-of-2024
Circular-17-of-2024
Size: 515 KB
Published: June 22, 2025
Circular 16 of 2024 – Renewal of Licences for the Production of Cannabis for Medicinal and Scientific Use.
Circular 16 of 2024 – Renewal of Licences for the Production of Cannabis for Medicinal and Scientific Use.
Size: 303 KB
Published: June 22, 2025
Circular 15 of 2024 – Importation of Unregistered Medicines by Community Pharmacists Under Statutory Instrument 57 of 2008
Circular 15 of 2024 – Importation of Unregistered Medicines by Community Pharmacists Under Statutory Instrument 57 of 2008
Size: 276 KB
Published: June 22, 2025
Circular No 14 of 2024 – Change of MCAZ Banking Details
Circular No 14 of 2024 – Change of MCAZ Banking Details
Size: 71 KB
Published: June 22, 2025
Circular-13-of-2024-Joint-ZAA-and-MCAZ-training
Circular-13-of-2024-Joint-ZAA-and-MCAZ-training
Size: 1,001 KB
Published: June 22, 2025
Circular 12 of 2024_IMPLEMENTATION PLAN FOR RE-REGISTRATION OF HUMAN ALLOPATHIC MEDICINES RE-REGISTRATION FEES
Circular 12 of 2024_IMPLEMENTATION PLAN FOR RE-REGISTRATION OF HUMAN ALLOPATHIC MEDICINES RE-REGISTRATION FEES
Size: 4 MB
Published: June 22, 2025
Circular 11 of 2024-SYSTEM CONFIGURATION TO ZIG
Circular 11 of 2024-SYSTEM CONFIGURATION TO ZIG
Size: 166 KB
Published: June 22, 2025
Circular 10 of 2024-Prevention of Diethylene Glycol (DEG) and Ethylene Glycol (EG) Contamination in Pharmaceticals
Circular 10 of 2024-Prevention of Diethylene Glycol (DEG) and Ethylene Glycol (EG) Contamination in Pharmaceticals
Size: 122 KB
Published: June 22, 2025
Circular 9 of 2024 – Wholesale Dealers Permit Renewals
Circular 9 of 2024 – Wholesale Dealers Permit Renewals
Size: 128 KB
Published: June 22, 2025
Circular-8-of-2024
Circular-8-of-2024
Size: 59 KB
Published: June 22, 2025
1 2 3

There are no download items matching this category criteria.

There are no download items matching this category criteria.

There are no download items matching this category criteria.

MCAZ Annual Report for the year ended 2017
MCAZ Annual Report for the year ended 2017
Size: 5 MB
Published: June 29, 2025
2016 Consolidated Financial Statements
2016 Consolidated Financial Statements
Size: 255 KB
Published: June 29, 2025
MCAZ Annual Report for the year ended 2015
MCAZ Annual Report for the year ended 2015
Size: 14 MB
Published: June 29, 2025
MCAZ Annual Report for the year ended 2013
MCAZ Annual Report for the year ended 2013
Size: 17 MB
Published: June 29, 2025
MCAZ Annual Report for the year ended 2011
MCAZ Annual Report for the year ended 2011
Size: 2 MB
Published: June 29, 2025
1 2

There are no download items matching this category criteria.

There are no download items matching this category criteria.

MCAZ DG’s New Year Message
MCAZ DG’s New Year Message
Size: 805 KB
Published: June 29, 2025
MEDIA RELEASE – MCAZ SIGNS MOU WITH SOUTH AFRICA HEALTH PRODUCTS REGULATOR -12 JANUARY 2024
MEDIA RELEASE – MCAZ SIGNS MOU WITH SOUTH AFRICA HEALTH PRODUCTS REGULATOR -12 JANUARY 2024
Size: 182 KB
Published: June 29, 2025
PRESS STATEMENT – MCAZ CONFISCATES 450 BOTTLES OF ILLEGAL COUGH SYRUPS (BRONCLEER AND ADCO-SALTERPYN) AT OLD TRAFFORD FLATS, BELVEDERE, HARARE.
PRESS STATEMENT – MCAZ CONFISCATES 450 BOTTLES OF ILLEGAL COUGH SYRUPS (BRONCLEER AND ADCO-SALTERPYN) AT OLD TRAFFORD FLATS, BELVEDERE, HARARE.
Size: 57 KB
Published: June 29, 2025
PRESS STATEMENT – MCAZ TAKES A STAND AGAINST DRUG ABUSE
PRESS STATEMENT – MCAZ TAKES A STAND AGAINST DRUG ABUSE
Size: 95 KB
Published: June 29, 2025
PRESS STATEMENT- REGULATORY ALERT REGARDING UNAUTHORISED BUYING AND SELLING OF SPECIALLY RESTRICTED PREPARATIONS AND THALIDOMIDE
PRESS STATEMENT- REGULATORY ALERT REGARDING UNAUTHORISED BUYING AND SELLING OF SPECIALLY RESTRICTED PREPARATIONS AND THALIDOMIDE
Size: 55 KB
Published: June 29, 2025
PRESS STATEMENT – UNSAFE USE OF GLUTATHIONE AND INJECTABLE VITAMINS AS SKIN LIGHTENING AGENTS
PRESS STATEMENT – UNSAFE USE OF GLUTATHIONE AND INJECTABLE VITAMINS AS SKIN LIGHTENING AGENTS
Published: June 29, 2025
PRESS STATEMENT – SUBSTANDARD (CONTAMINATED) PAEDIATRIC MEDICINES IDENTIFIED IN WHO REGION OF AFRICA
PRESS STATEMENT – SUBSTANDARD (CONTAMINATED) PAEDIATRIC MEDICINES IDENTIFIED IN WHO REGION OF AFRICA
Size: 618 KB
Published: June 29, 2025
PRESS STATEMENT – 25TH ANNIVERSARY 2022
PRESS STATEMENT – 25TH ANNIVERSARY 2022
Size: 151 KB
Published: June 29, 2025
PRESS STATEMENT – ILLEGAL ADVERTISING AND SELLING OF SUPERLIFE TOTAL CARE (STC30) IN ZIMBABWE
PRESS STATEMENT – ILLEGAL ADVERTISING AND SELLING OF SUPERLIFE TOTAL CARE (STC30) IN ZIMBABWE
Size: 54 KB
Published: June 29, 2025
PRESS STATEMENT – SUBSTANDARD (CONTAMINATED) SYRUP MEDICINES IDENTIFIED IN WHO REGION OF AFRICA
PRESS STATEMENT – SUBSTANDARD (CONTAMINATED) SYRUP MEDICINES IDENTIFIED IN WHO REGION OF AFRICA
Size: 67 KB
Published: June 29, 2025
PRESS STATEMENT – APPOINTMENT OF SUBSTANTIVE DIRECTOR-GENERAL
PRESS STATEMENT – APPOINTMENT OF SUBSTANTIVE DIRECTOR-GENERAL
Size: 46 KB
Published: June 29, 2025
1 2